Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future

Antimicrob Agents Chemother. 2015 Apr;59(4):2474. doi: 10.1128/AAC.05173-14.

¹ University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
² University of Groningen, University Medical Center Groningen, Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
³ University of Groningen, University Medical Center Groningen, Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands.
⁴ University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands j.w.c.alffenaar@umcg.nl.

No abstract available

Publication types